Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii

Clinical Infectious Diseases

Volumn 28, Issue 5, 1999, Pages 1008-1011

  Levin, Anna S ^a,b   Barone, Antonio A ^a   Penço, Juliana ^a   Santos, Marcio V ^a   Marinho, Ivan S ^a   Arruda, Erico A G ^a   Manrique, Edison I ^a   Costa, Silvia F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Rua Harmonia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIMETHATE; COLISTIN; CREATININE; GENTAMICIN; IMIPENEM; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLONE DERIVATIVE; TICARCILLIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; FEMALE; HOSPITAL INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEPHROTOXICITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME;

EID: 0032939527     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514732     Document Type: Article

References (26)

1. 1. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9:148-65.
2. 2. Livermore DM. Are all β-lactams created equal? Scand J Infect Dis 1996; 101:33-43.
3. 3. Levin AS, Mendes CMF, Sinto SI, et al. An outbreak of multiresistant Acinetobacter baumannii in a university hospital in São Paulo, Brazil. Infect Control Hosp Epidemiol 1996; 17:366-8.
4. 4. Sader HS, Pignatari AC, Leme JL, et al. Epidemiologic typing of multiple drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit. Diagn Microbiol Infect Dis 1993; 17:13-8.
5. 5. Catchpole CR, Andrews JM, Brenwald N, Wise R. A reassessment of the in-vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 1997; 39:255-60.
6. 6. Horton J, Pankey GA. Polymyxin B, colistin, and sodium colistimethate. Med Clin North Am 1982; 66:135-42.
7. 7. Kunin CM, Bugg A. Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J Infect Dis 1971; 124:394-400.
8. 8. Garner JS, Jarvis WR, Emori TG, Horn TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
9. 9. Gilligan PH. Pseudomonas and Burkholderia. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press, 1995:509-19.
10. 10. Gravenitz A. Acinetobacter, Alcaligenes, Moraxella and other nonfermentative gram-negative bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press, 1995:520-32.
11. 11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
12. 12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Vol 14. NCCLS document M2-M5 (M100-S5). Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1994.
13. 13. Barnett M, Bushby SRM, Wilkinson S. Sodium sulphomethyl derivatives of polymyxins. Br J Pharmacol 1964; 23:552-74.
14. 14. Hoeprich PD. The polymyxins. Med Clin North Am 1970; 54:1257-65.
15. 15. Goodwill NJ. Colistin and sodium colistimethate. Med Clin North Am 1970; 54:1267-76.
16. 16. Petersdorf RG, Plorde JJ. Colistin - a reappraisal. JAMA 1963; 183: 123-5.
17. 17. Yow EM, Tan E, Shane L, Schonfeld S, Abu-Nassar H. Colistin (Coly-Mycin) in resistant bacterial infections. Arch Intern Med 1961; 108: 64-70.
18. 18. Kirby WMM, Roberts CE Jr. Colistin. JAMA 1961; 177:112.
19. 19. Edgar WM, Dickinson KM. A trial of colistin methane sulphonate in urinary infection with Pseudomonas pyocyanea. Lancet 1962; 2: 739-40.
20. 20. Fekety FR Jr, Norman PS, Cluff LE. The treatment of gram-negative bacillary infections with colistin. Ann Intern Med 1962; 57:214-29.
21. 21. Walker SH, Patron LR. Colistin therapy in infants and children. Am J Dis Child 1965; 109:204-11.
22. 22. Marsden HB, Hyde WA. Colistin methane sulphonate in childhood infections. Lancet 1962; 2:740-2.
23. 23. Goodwin NJ, Friedman EA. The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels. Ann Intern Med 1968; 68:984-94.
24. 24. MacKay DN, Kaye D. Serum concentrations of colistin in patients with normal and impaired renal function. N Engl J Med 1964; 270:394-7.
25. 25. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Ann Intern Med 1970; 72: 857-68.
26. 26. Wolinsky E, Hines JD. Neurotoxic and nephrotoxic effects of colistin in patients with renal disease. N Engl J Med 1962; 266:759-62.